SCHEMBL27728530

SCHEMBL27728530

CCCCc1cnn(-c2cccc(CN3CCOCC3)c2)c1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCF1 P14598 1/20 0.45
▸ TLR7 Q9NYK1 5/20 0.45
▸ NOS1 P29475 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ USP7 Q93009 1/20 0.40
▸ FGFR1 P11362 2/20 0.40
▸ SRC P12931 2/20 0.40
▸ FGFR2 P21802 2/20 0.40
▸ FGFR4 P22455 2/20 0.40
▸ FGFR3 P22607 2/20 0.40
▸ KDR P35968 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27728431 0.87 MAPK14 (0.45) TLR7NOS1MEN1KMT2AMAPK14
SCHEMBL28784327 0.75 MAPK14 (0.48) MEN1KMT2AMAPK14HPGDNPC1
SCHEMBL27676109 0.74 RAB9A (0.49) MEN1ALDH1A1KMT2AMAPK14HPGD
SCHEMBL27728529 0.74 TYRO3 (0.45) NCF1TLR7NOS1MEN1ALDH1A1
SCHEMBL27705945 0.74 SMN1; SMN2 (0.51) NCF1TLR7NOS1MEN1KMT2A
SCHEMBL10244180 0.70 NCF1 (0.67) NCF1NOS1MEN1ALDH1A1KMT2A
SCHEMBL28053397 0.70 ALDH1A1 (0.42) MEN1ALDH1A1KMT2AFGFR1FGFR2
SCHEMBL30704930 0.70 NCF1 (0.49) NCF1NOS1MEN1ALDH1A1KMT2A
SCHEMBL1407899 0.70 NCF1 (0.49) NCF1NOS1MEN1ALDH1A1KMT2A
SCHEMBL27594166 0.69 HPGD (0.51) NCF1NOS1MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101198607-A Phenylacetamides suitable as protein kinase inhibitors NOVARTIS AG (CH) 2008-06-11 — — CN disclosed
Send feedback